Clinical Trial Update: Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating reduced-dose chemotherapy followed by blinatumomab as induction therapy for newly diagnosed Philadelphia-negative B-cell acute lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-negative B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Chen Suning | Conditions: B Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED